Teva Pharma's most recent trend suggests a bearish bias. One trading opportunity on Teva Pharma is a Bear Call Spread using a strike $41.00 short call and a strike $46.00 long call offers a potential 21.07% return on risk over the next 7 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $41.00 by expiration. The full premium credit of $0.87 would be kept by the premium seller. The risk of $4.13 would be incurred if the stock rose above the $46.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Teva Pharma is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Teva Pharma is bearish.
The RSI indicator is at 34.11 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Teva Pharma
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Teva Pharmaceutical Industries Ltd. and Certain Officers – TEVA
Fri, 11 Nov 2016 02:29:12 GMT
GlobeNewswire – NEW YORK, Nov. 10, 2016– Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. and certain of its officers. The class action, filed in United States …
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Teva Pharmaceutical Industries Limited and Encourages Investors with Losses to Contact the Firm
Thu, 10 Nov 2016 18:23:00 GMT
Accesswire – LOS ANGELES, CA / ACCESSWIRE / November 10, 2016 / Lundin Law PC , a shareholder rights firm, announces a class action lawsuit has been filed against Teva Pharmaceutical Industries Limited (“Teva” …
War and Peace in Trumpland: Here Is Why You Buy These 4 Stocks Now
Thu, 10 Nov 2016 15:28:00 GMT
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Teva Pharmaceutical Industries Limited (TEVA) and Lead Plaintiff Deadline – January 5, 2017
Thu, 10 Nov 2016 15:10:00 GMT
GlobeNewswire – NEW YORK, Nov. 10, 2016– Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed against Teva Pharmaceutical Industries Limited and certain …
Short Interest Bets Increase on Major Pharma
Thu, 10 Nov 2016 12:40:14 GMT
Also on Market Tamer…
Follow Us on Facebook